CERA

unofficial impact factor 1.46
Search for
Advanced search
Cost Effectiveness and Resource Allocation
Tools
Open Access Highly Access Email this article to a friend

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

Shalini L Kulasingam*, Steve Benard, Ruanne V Barnabas, Nathalie Largeron and Evan R Myers

Cost Effectiveness and Resource Allocation 2008, 6:4 doi:10.1186/1478-7547-6-4

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.